Abstract:Background: Danon disease is characterized by the failure of lysosomal biogenesis, maturation, and function due to a deficiency of lysosomal membrane structural protein (LAMP2). Methods: The current report describes a female patient with a sudden syncope and hypertrophic cardiomyopathy phenotype. We identified the pathogenic mutations in patients by whole-exon sequencing, followed by a series of molecular biology and genetic approaches to identify and functional analysis of the mutations. Results: Suggestive findings by cardiac magnetic resonance (CMR), electrocardiogram (ECG), and laboratory examination suggested Danon disease which was confirmed by genetic testing. The patient carried a novel de novo mutation, LAMP2 c.2T>C located at the initiation codon. The quantitative polymerase chain reaction (qPCR) and Western blot (WB) analysis of peripheral blood leukocytes from the patients revealed evidence of LAMP2 haploinsufficiency. Labeling of the new initiation codon predicted by the software with green fluorescent protein followed by fluorescence microscopy and Western blotting showed that the first ATG downstream from the original initiation codon became the new translational initiation codon. The three-dimensional structure of the mutated protein predicted by alphafold2 revealed that it consisted of only six amino acids and failed to form a functional polypeptide or protein. Overexpression of the mutated LAMP2 c.2T>C showed a loss of function of the protein, as assessed by the dual-fluorescence autophagy indicator system. The mutation was confirmed to be null, AR experiments and sequencing results confirmed that 28% of the mutant X chromosome remained active. Conclusion: We propose possible mechanisms of mutations associated with haploinsufficiency of LAMP2: (1) The inactivation X chromosome carrying the mutation was not significantly skewed. However, it decreased in the mRNA level and the expression ratio of the mutant transcripts; (2) The identified mutation is null, and the active mutant transcript fails to translate into the normal LAMP2 proteins. The presence of haploinsufficiency in LAMP2 and the X chromosome inactivation pattern were crucial factors contributing to the early onset of Danon disease in this female patient.

Detection of somatic and germline mosaicism for the LAMP2 gene mutation c.808dupG in a Chinese family with Danon disease.

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Identification of LAMP2 Mutations in Early-Onset Danon Disease with Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.

Danon Disease Caused by Two Novel Mutations of the LAMP2 Gene: Implications for Two Ends of the Clinical Spectrum

Novel LAMP2 mutations in Chinese patients with Danon disease cause varying degrees of clinical severity.

Case Report: Identification of Mutations in LAMP2 in Two Chinese Infants with Danon Disease

A Novel LAMP2 P.g93r Mutation Associated with Mild Danon Disease Presenting with Familial Hypertrophic Cardiomyopathy.

Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease

A Family with Danon Disease Caused by a Splice Site Mutation in LAMP2 That Generates a Truncated Protein.

De novo LAMP2 insertion mutation causes cardiac-only Danon disease: A case report

Identification of a novel splicing-altering LAMP2 variant in a Chinese family with Danon disease

Danon disease: a case report and literature review

Identification of a novel splicing‐altering <i>LAMP2</i> variant in a Chinese family with Danon disease

Clinical and Pathological Features of Danon Disease Associated with a Novel Lysosome-Associated Membrane Protein-2B Mutation

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Case Report: A Novel LAMP2 Splice-Altering Mutation Causes Cardiac-Only Danon Disease

Amelioration of X-Linked Related Autophagy Failure in Danon Disease with DNA Methylation Inhibitor

Clinical and genetic profile of Chinese children with Danon disease: A single-center retrospective cohort study

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

A case report of delayed diagnosis of danon disease Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene